简体中文
  http://www.jcps.ac.cn  
Home   |   About Journal   |   Editorial Board   |   For Authors   |   Subscriptions   |   Contacts Us
Journal of Chinese Pharmaceutical Sciences  2018, Vol. 27 Issue (10): 675-685    DOI: 10.5246/jcps.2018.10.069
Original articles Current Issue | Archive | Adv Search |
A new compound W026B alleviates ischemic brain injury through inhibiting the production of inflammatory cytokines in pMCAO and tMCAO, and enhances the beneficial effect of tPA
Ye Zhang1, Danping Zheng1, Mengyang Shui1, Ye Liu2, Xiaoyan Liu1*, Yinye Wang1*
1. Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
2. Beijing Honghui New Medical Technology Co.Ltd.; Beijing Daxing Biological Medicine Industry Base, Beijing 102600, China
京ICP备05051953号-6
 Copyright © Journal of Chinese Pharmaceutical Sciences, School of  Pharmaceutical Sciences, Peking University
Tel./Fax: +86-10-82801713, E-mail: jcps@bjmu.edu.cn
Support by
Beijing Magtech Co.ltd , E-mail: support@magtech.com.cn